(Q33373494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

S M Said

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

J Hahn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

E Schleyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M Müller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M Buerke

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

R Prondzinsky

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

8 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

Clinical Research in Cardiology

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

61-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00392-006-0459-7

22 December 2019

exact match

0 references

cites work

Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0459-7

Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0459-7

Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00392-006-0459-7

Drug-induced immune thrombocytopenia: an overview of pathogenesis

21 January 2018

1 reference

12 December 2020

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug.

1 reference

12 December 2020

Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.

1 reference

12 December 2020

Heparin-induced thrombocytopenia and thrombosis

1 reference

12 December 2020

Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation--a possible new indication for high dose i.v. IgG.

1 reference

12 December 2020

Platelet function inhibitors in the Year 2000

1 reference

12 December 2020

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

12 December 2020

Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier

1 reference

12 December 2020

Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis

1 reference

12 December 2020

Analysis of bleeding complications associated with glycoprotein IIb/IIIa receptors blockade in patients with high-risk acute coronary syndromes: insights from the PRISM-PLUS study

1 reference

12 December 2020

Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting

1 reference

12 December 2020

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

12 December 2020

Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy

1 reference

12 December 2020

Abciximab readministration: results of the ReoPro Readministration Registry

1 reference

12 December 2020

Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors

1 reference

12 December 2020

Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Reversible thrombocytopenia associated with eptifibatide

1 reference

12 December 2020

Oral platelet glycoprotein IIb/IIIa inhibitors.

1 reference

12 December 2020

Practical approach to the diagnosis and management of thrombocytopenia associated with tirofiban treatment

1 reference

12 December 2020

Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia

1 reference

12 December 2020

Association of eptifibatide and acute profound thrombocytopenia

1 reference

12 December 2020

Successful use of eptifibatide as an adjunct to coronary stenting in a patient with abciximab-associated acute profound thrombocytopenia

1 reference

12 December 2020

Clinical pharmacology of eptifibatide

1 reference

12 December 2020

Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors

1 reference

12 December 2020

Eptifibatide-associated acute, profound thrombocytopenia

1 reference

12 December 2020

Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab

1 reference

12 December 2020

Delayed profound thrombocytopenia after c7E3 Fab (abciximab) therapy

1 reference

12 December 2020

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

12 December 2020

Fibrinolytic therapy of acute myocardial infarction in the heparin thrombosis syndrome

1 reference

12 December 2020

Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

1 reference

12 December 2020

Acute profound thrombocytopenia associated with anaphylactic reaction after abciximab therapy during percutaneous coronary angioplasty

1 reference

12 December 2020

Heparin-induced thrombosis-thrombocytopenia syndrome in Crohn disease. Further thromboses with oral anticoagulation after discontinuation of heparin

1 reference

12 December 2020

Severe intracranial hemorrhage after emergency carotid stenting and abciximab administration for postoperative thrombosis

1 reference

12 December 2020

Oral glycoprotein IIb/IIIa antagonists: new insights from the SYMPHONY trial

1 reference

12 December 2020

Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion

1 reference

12 December 2020

Association between ligand-induced conformational changes of integrin IIbbeta3 and IIbbeta3-mediated intracellular Ca2+ signaling

1 reference

12 December 2020

The heparin-induced thrombosis-thrombocytopenia syndrome

1 reference

12 December 2020

Possible anaphylactic reaction to abciximab

1 reference

12 December 2020

Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology

1 reference

12 December 2020

Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin

1 reference

12 December 2020

Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy

1 reference

12 December 2020

Immune endothelial-cell injury in heparin-associated thrombocytopenia

1 reference

12 December 2020

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment

1 reference

12 December 2020

Glycoprotein IIb/IIIa antagonists: potential induction and detection of drug-dependent antiplatelet antibodies

1 reference

12 December 2020

Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization. Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) Study Group

1 reference

12 December 2020

Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets

1 reference

12 December 2020

Profound thrombocytopenia associated with tirofiban: case report and review of literature

1 reference

12 December 2020

Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment

1 reference

12 December 2020

Pathomorphological aspects of heparin-induced thrombocytopenia II (HIT-II syndrome).

1 reference

12 December 2020

Drug-induced thrombocytopenia: an updated systematic review

1 reference

12 December 2020

Eptifibatide-induced thrombocytopenia and coronary bypass operation

1 reference

12 December 2020

10.1007/S00392-006-0459-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146606%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference